Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2016

Open Access 01-12-2016 | Research article

Increased risk for urological cancer associated with anxiety disorder: a retrospective cohort study

Authors: Yung-Chan Chen, Li-Ting Kao, Herng-Ching Lin, Hsin-Chien Lee, Chung-Chien Huang, Shiu-Dong Chung

Published in: BMC Urology | Issue 1/2016

Login to get access

Abstract

Background

Anxiety disorders (ADs) are common with a high rate of medical comorbidities. Although the association between ADs and the overall cancer risk remains controversial, patients with ADs were found to be more likely to develop specific cancer types. Herein, we estimated the risk of developing urological cancers among patients with ADs in a 5-year follow-up period using a population-based database.

Methods

Two study cohorts were identified from the Taiwan Longitudinal Health Insurance Database 2005: patients with ADs, and comparison subjects selected by one-to-one matching for sex, age, and the year of recruitment. Follow-up was undertaken to determine whether sampled patients and comparison subjects had developed urological cancers in the subsequent 5 years.

Results

We found that urological cancers occurred among 0.54% of patients with ADs and 0.13% of comparison subjects. After adjusting for sociodemographic characteristics, medical comorbidities, and alcohol and tobacco use disorder, the stratified Cox proportional hazard regression suggested that patients with ADs were more likely to develop urological cancers relative to comparison subjects (adjusted hazard ratio, 3.67; 95% confidence interval, 2.85 ~ 4.72). The adjusted HR for males with ADs was 3.82 (95% CI: 2.79 ~ 5.23) in comparison to males without ADs. In addition, the adjusted HR for females with ADs was 3.47 (95% CI: 2.26 ~ 5.31) than those females without ADs.

Conclusions

We concluded that during the 5-year follow-up period, there was a significantly increased risk of urological cancers among patients with ADs.
Literature
1.
Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry. 2006;51:100–13.CrossRefPubMed
2.
Marques L, Robinaugh DJ, LeBlanc NJ, Hinton D. Cross-cultural variations in the prevalence and presentation of anxiety disorders. Expert Rev Neurother. 2011;11:313–22.CrossRefPubMed
3.
Faravelli C, Guerrini Degl'Innocenti B, Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand. 1989;79:308–12.CrossRefPubMed
4.
Chen CN, Wong J, Lee N, Chan-Ho MW, Lau JT, Fung M. The Shatin community mental health survey in Hong Kong. II. Major findings. Arch Gen Psychiatry. 1993;50:125–33.CrossRefPubMed
5.
Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157:669–82.CrossRefPubMed
6.
Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, et al. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety. 2005;21:178–84.CrossRefPubMed
7.
Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147–55.CrossRefPubMed
8.
Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008;5:466–75.CrossRefPubMed
9.
Hamer M, Chida Y, Molloy GJ. Psychological distress and cancer mortality. J Psychosom Res. 2009;66:255–8.CrossRefPubMed
10.
Aro AR, De Koning HJ, Schreck M, Henriksson M, Anttila A, et al. Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland. Psychol Med. 2005;35:1515–21.CrossRefPubMed
11.
Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J. Cancer in people with depression or anxiety: record-linkage study. Soc Psychiatry Psychiatr Epidemiol. 2007;42:683–9.CrossRefPubMed
12.
Liang JA, Sun LM, Su KP, Chang SN, Sung FC, et al. A nationwide population-based cohort study: will anxiety disorders increase subsequent cancer risk? PLoS One. 2012;7:e36370.CrossRefPubMedPubMedCentral
13.
Shen CC, Hu YW, Hu LY, Hung MH, Su TP, et al. The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study. PLoS One. 2013;8:e57399.CrossRefPubMedPubMedCentral
14.
Siddiqui EJ, Shabbir M, Thompson CS, Mumtaz FH, Mikhailidis DP. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved? Anticancer Res. 2005;25:4281–6.PubMed
15.
Siddiqui EJ, Shabbir MA, Mikhailidis DP, Mumtaz FH, Thompson CS. The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation. BJU Int. 2006;97:634–9.CrossRefPubMed
16.
Chen YH, Yeh HY, Wu JC, Haschler I, Chen TJ, Wetter T. Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics. 2011;86:365–80.
17.
Jones ME, Swerdlow AJ. Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol. 1998;148:1012–7.CrossRefPubMed
18.
McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R. Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization. J Clin Psychiatry. 2006;67:1187–93.CrossRefPubMed
19.
Chung SD, Lin HC. Association between chronic prostatitis/chronic pelvic pain syndrome and anxiety disorder: a population-based study. PLoS One. 2013;8:e64630.CrossRefPubMedPubMedCentral
20.
Chung KH, Liu SP, Lin HC, Chung SD. Bladder pain syndrome/interstitial cystitis is associated with anxiety disorder. Neurourol Urodyn. 2014;33:101–5.CrossRefPubMed
21.
Lykouras L, Michopoulos J. Anxiety disorders and obesity. Psychiatrike. 2011;22:307–13.PubMed
22.
Sabourin BC, Hilchey CA, Lefaivre MJ, Watt MC, Stewart SH. Why do they exercise less? Barriers to exercise in high-anxiety-sensitive women. Cogn Behav Ther. 2011;40:206–15.CrossRefPubMed
23.
Sommer F, Klotz T, Schmitz-Drager BJ. Lifestyle issues and genitourinary tumours. World J Urol. 2004;21:402–13.CrossRefPubMed
24.
Kao CH, Sun LM, Su KP, Chang SN, Sung FC, et al. Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. J Clin Psychiatry. 2012;73:e555–60.CrossRefPubMed
25.
Pottegard A, Friis S, Andersen M, Hallas J. Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case–control study. Br J Clin Pharmacol. 2013;75:1356–64.CrossRefPubMed
26.
Selaman Z, Bolton JM, Oswald T, Sareen J. Association of benzodiazepine use with increased cancer risk is misleading due to lack of theoretical rationale and presence of many confounding factors. J Clin Psychiatry. 2012;73:1264.CrossRefPubMed
27.
Cohen S, Herbert TB. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol. 1996;47:113–42.CrossRefPubMed
28.
Sephton S, Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun. 2003;17:321–8.CrossRefPubMed
29.
Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617–25.CrossRefPubMed
30.
Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006;6:240–8.CrossRefPubMedPubMedCentral
31.
Eismann EA, Lush E, Sephton SE. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology. 2010;35:963–76.CrossRefPubMed
32.
Dizeyi N, Bjartell A, Nilsson E, Hansson J, Gadaleanu V, et al. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate. 2004;59:328–36.CrossRefPubMed
33.
Shinka T, Onodera D, Tanaka T, Shoji N, Miyazaki T, et al. Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line. Oncol Lett. 2011;2:211–5.PubMedPubMedCentral
34.
Akimova E, Lanzenberger R, Kasper S. The serotonin-1A receptor in anxiety disorders. Biol Psychiatry. 2009;66:627–35.CrossRefPubMed
35.
Siddiqui EJ, Thompson CS, Mikhailidis DP, Mumtaz FH. The role of serotonin in tumour growth (review). Oncol Rep. 2005;14:1593–7.PubMed
36.
Jungwirth N, Haeberle L, Schrott KM, Wullich B, Krause FS. Serotonin used as prognostic marker of urological tumors. World J Urol. 2008;26:499–504.CrossRefPubMed
37.
38.
Schury K, Kolassa IT. Biological memory of childhood maltreatment: current knowledge and recommendations for future research. Ann N Y Acad Sci. 2012;1262:93–100.CrossRefPubMed
39.
Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, et al. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiat. 2010;67(2):113–23.CrossRefPubMedPubMedCentral
40.
Morath J, Moreno-Villanueva M, Hamuni G, Kolassa S, Ruf-Leuschner M, Schauer M, et al. Effects of psychotherapy on DNA strand break accumulation originating from traumatic stress. Psychother Psychosom. 2014;83(5):289–97.CrossRefPubMed
Metadata
Title
Increased risk for urological cancer associated with anxiety disorder: a retrospective cohort study
Authors
Yung-Chan Chen
Li-Ting Kao
Herng-Ching Lin
Hsin-Chien Lee
Chung-Chien Huang
Shiu-Dong Chung
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2016
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-016-0187-x

Other articles of this Issue 1/2016

BMC Urology 1/2016 Go to the issue

Research article

Determinants of peri-operative blood transfusion in a contemporary series of open prostatectomy for benign prostate hyperplasia

Study protocol

Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial

Research article

Female urinary incontinence and wellbeing: results from a multi-national survey

Research article

Frequent mismatch-repair defects link prostate cancer to Lynch syndrome

Research article

Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer

Research article

Characteristics and repair outcome of patients with Vesicovaginal fistula managed in Jimma University teaching Hospital, Ethiopia